Publication Ethics and Malpractice
In dealing with cases in research and publication, IJRPST using guidelines issued by the Committee on Publication Ethics (Commission of Publication Ethics / COPE). IJRPST requires that all articles involving pharmaceutical sciences subjects to respect the principles of research ethics.
As an important issue, ethical publication should be clear in order to improve the quality of research. IJRPST adapts COPE to meet the ethical standards both for publishers, editors, authors, and reviewers. In order to uphold these ethical standards, the publisher does not have the right to interfere with the integrity of the contents and the only support to publish in a timely manner.
Here are the ethical standards for editors, authors, and reviewers.
Disclosure and conflicts of interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learns from a third party that a published work contains a significant error, it is the obligation of the author to promptly.
Authors submitting articles to IJPRS has to follow some bioethics when a research is carried on living organisms and Biosecurity. Researches carried out on living amphibians, vertebrates or invertebrates should have been carried out with ethical guidelines and regulations. Sex and other characteristics that influence the results have to be described. For experiments involving human subjects, authors must recognize the committee favoring the researches, and should include with their submission a comment affirming that illuminated consent was acquired from all subjects.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© 2018, International Journal of Research In Pharmaceutical Chemistry and Analysis